ArticleFrontiers in immunology2026
Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma.
Biyan Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.